DPP-4 inhibitors are commonly referred to by which suffix?

Prepare for the Glucose Management Test with interactive quizzes featuring multiple choice questions, hints, and detailed explanations. Boost your confidence and be exam-ready!

Multiple Choice

DPP-4 inhibitors are commonly referred to by which suffix?

Explanation:
DPP-4 inhibitors are identified by the suffix -gliptins. This naming signal helps you recognize the drug class just from the name: sitagliptin, saxagliptin, linagliptin, and alogliptin are all examples of DPP-4 inhibitors. The mechanism is to inhibit the enzyme dipeptidyl peptidase-4, which slows the breakdown of incretin hormones, thereby enhancing glucose-dependent insulin secretion. The other suffixes correspond to different diabetes drug classes: -glitazones are thiazolidinediones, -formin is metformin, and -tide is used for peptide-based drugs like GLP-1 receptor agonists.

DPP-4 inhibitors are identified by the suffix -gliptins. This naming signal helps you recognize the drug class just from the name: sitagliptin, saxagliptin, linagliptin, and alogliptin are all examples of DPP-4 inhibitors. The mechanism is to inhibit the enzyme dipeptidyl peptidase-4, which slows the breakdown of incretin hormones, thereby enhancing glucose-dependent insulin secretion. The other suffixes correspond to different diabetes drug classes: -glitazones are thiazolidinediones, -formin is metformin, and -tide is used for peptide-based drugs like GLP-1 receptor agonists.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy